Participants looking for partners will have a unique opportunity to present their organisations and ideas and/or expertise for project proposals in front of the audience in the form of a brief oral presentation (5 minutes max. and only one presentation per entity/lab or proposal idea).
For the presentation during the oral session please use this TEMPLATE.pptx with recommendations included.
Please note that due to time constraints, the selection criteria will follow the next order or preference:
1. Project ideas linked to specific topics (coordinator looking for partners)
2. Expertise offer linked to specific topics (priority to widening countries* then first come first served basis). *List of widening countries
3. General expertise offer
Presentation order during the event will be in accordance to the date of reception of the final version of PowerPoint presentation and not the date of registration.
In order to help you to prepare better your pitch, at this LINK you can find a basic guideline with some suggestions and tips.
Deadline to submit your presentation: 24 April 2025 EOB
Please send your presentation in PDF and PPT format with the following subject: Pitch presentation Cluster 1 – Name of the organisation to vania.rosas-magallanes@recherche.gouv.fr and ewa.szkiladz@ncbr.gov.pl
Pitching session:
- Songül Varlı, Yildiz Technical University, Computer Engineering(Turkey) “Computer Vision Research Group”
- Chiara Baudracco, EURECAT Technology Research Center (Spain) “Empowering Adaptive Lifelong Ecosystems for Intellectual Disabilities”
- Daria Stelmashenko, geneXplain GmbH (Germany) “Mastering gene regulation for advanced precision medicine applications”
- Guillermo Llopis, ProtForge (Spain) „AI-Driven Protein Design: Unlocking the Future of Therapeutic Antibodies”
- Jo Van Vaerenbergh, SPINDLE (Switzerland) “The Hybrid Metaverse Frailty Clinic”
- Sara Karaki, Bordeaux University Hospital (France) „Bordeaux University Hospital: Expertise, Partnerships, and European Ambitions”
- Keita Augstkalne, Fungo Health (Latvia) “Improving pediatric patient outcomes through gamified, augmented reality - based mobile platform.”
- Lidia Urbina Treviño, Lead Discovery Center GmbH (Germany) “TTLL Inhibitors for the Treatment of Neurological Diseases”
- Sheeba Santhini Manoharan-Basil, Institute of Tropical Medicine (Belgium) “Using experimental models to establish maximum antimicrobial residue LIMITs for food that do not include antimicrobial resistance (AMR) (LIMIT-AMR Study)”
- Soizic Rozand, ALCEDIAG (France) „The power of RNA & AI for diagnostics in mental health”
- Bram Lievens, Vrije Universiteit Brussel (Belgium) ” Towards more human-centered and trustworthy health technologies”
- Elżbieta Dobrzyńska, Central Institute for Labour Protection – National Research Institute (Poland) “Micro- and nanoplastics in the work environment”
- Joseph Olajumoke, Lagos Waste Forum (Nigeria) ” Surveillance of micro- and nanoplastics among individuals in Nigeria, and its impact on infectious disease outcomes”
- Maria Mastrangelopoulou, Coremine Vitae AS (Norway) “Empowering Precision Medicine: AI-Driven Clinical Decision Support Platform”
- Marija Šola Spasić, Institute for Cardiovascular Diseases “Dedinje” (Serbia) “IKVBD expertise for Cluster 1 topics”
- Martha Zachariadou, Ergobyte Informatics S.A. (Greece) “Expert Systems in Digital Health”
- Rebeca García Betances, Tree Technology S.A (Spain) “Proposal ideas for HORIZON-HLTH-2025-01-DISEASE-02 & HORIZON-HLTH-2025-01-ENVHLTH-01”
- Stephanie Bezzina Wettinger, University of Malta (Malta) “Analysing Human Multiomic Data to Rapidly Identify Better Candidate Drug Targets”
- Tugce Schmitt, Maastricht University (The Netherlands) “XR4Autism: Extended Reality and Smart Environments to Enhance Life for People with Autism”
- Wujun Xu, University of of Eastern Finland, University of Toronto (Finland & Canada) “Machine learning-driven mRNA/ CRISPR delivery with bioinspired nanoparticles”
- Zahra Moussavi, University of Manitoba (Canada) “NeuroPlay@Home: A virtual reality Gym for the healthy brain aging”
- Magdalena Morze, Jacek Krzywy, Łukasiewicz - Poznan Instutite of Technology (Poland) „Human Robot Interactions: The Potential of Using Social Robots in Hospitals and Elderly Care”
- Daniel Duhautbout, AiiNTENSE (France) „Supporting Parkinson's disease with real-life data”
- Sarah Terreri, PAL Robotics (Spain, Italy, France) “Robotics and AI in healthcare”
The high quality presentations received but not selected, are available below:
- Afra Sena GÜNASLAN, Green Crescent-NationalSociety (Turkey) “ The GREEN CRESCENT”
- Aigli Korfiati, Deeplab (Greece) „Leveraging AI & deep learning to transform life sciences”
- Alba Tuset, MiWEndo Solutions (Spain) “e-BIOPSY: Innovative solution based on microwaves and additive manufacturing for the real-time classification of polyps in colonoscopies”
- Alexander Nikolov & Romana Hessler, SYNYO GmbH (Austria) ” Your Trusted Partner with Expertise in Coordination, Dissemination, and Exploitation”
- Alfonso Gautieri, Politecnico di Milano (Italy) “Molecular and cellular effects of nanoplastics”
- Andras Dinnyes, BioTalentum Ltd (Hungary) ” In vitro human-cell based methods for pollutant and plastic toxicology (NAM) and ATMP manufacturing”
- András József Laki, Pázmány Péter Catholic University (Hungary) “Development of Lab-on-a-Chip (LOC) / Organ-on-a-Chip (OOC)”
- Andrea Comella, Creatio (Spain) “Creatio: End-to-End Development of therapies — From Discovery to Clinical-Grade Manufacturing”
- Arvydas Laurinavicius, Vilnius University (Lithuania) “Digital Health Intelligence Ecosystem”
- Attila Csikász-Nagy, Cytocast (Hungary) “Predicting Outcomes, Enhancing Safety The CYTOCAST DIGITAL TWIN Platform™ is designed to predict drug candidate side effects and helps avoid drug registration failure”
- Axel Brando, Barcelona Supercomputing Center (Spain) “Multidisciplinary Research on Trustworthy AI”
- Balázs Babarczy, Syreon Research Institute (Hungary) “Implementing state-of-the-art mental health interventions in disadvantaged populations”
- Bassam Damaj, Veos Pharmaceuticals S.L (Spain) “ThymoTropin™ – A Breakthrough Natural Therapy for Muscle Loss in Aging & GLP-1 Patients”
- Birgit Morlion, VUB – Vrije Universiteit Brussel (Belgium) ” Smart HealthTech for a Healthier world”
- Bogdan J. Matuszewski, University of Central Lancashire (United Kingdom) “Advancing Biomedical Research with Generative AI”
- Boguslaw Obara, School of Computing, Newcastle University (United Kingdom) “Artificial Intelligence in BioMedical Imaging”
- Boris Vukovic & Majid Komeili, Accessibility Institute at Carleton University (Canada) ”Trustworthy AI-Assisted Assessment of Functional Limitations and Disability for Personalized Healthcare Support Services”
- Burcu BEKTAS GUNES, DATASURGERY Software and Consulting Inc (Türkiye) “DATASURGERY Redefining Medical Imaging with AI-Powered Innovation”r
- Christa Ivanova, MicrofluidicInnovation Center (France) ” Microfluidics for Health”
- Cristina Bernadó, Gene Vector Barcelona, S.L. (Spain) “Gene Vector Barcelona: Contributing to patient’s access to Advanced Therapies”
- Cristina Maccalli, IRCCS San Martino Hospital (Italy) “Advanced Cell Therapy Lab (TheraCell Lab)”
- Diana Vertelkiene, Health technology cluster iVita (Lithuania) “Personalized Epigenetic Nutrition”
- Dimitar Dimitrov, HCLS (Bulgaria) “HEALTH & LIFE SCIENCE CLUSTER BULGARIA”
- Dorit Cohen Carmon, ReSynapse Therapeutics (Israel) ”Multi-Target Drugs for Mental Health Disorders”
- Eija Metsälä & Toini Palo, Metropolia University of Applied sciences (Finland) “Using Generative AI and UX in co-developing personalised and value-based care for the most fatal elderly diseases and conditions”
- Elena González-Rey, Institute of Parasitology and Biomedicine López-Neyra (IPBLN) (Spain) “NEUROIMMUNOLOGY OF INFECTIOUS, INFLAMMATORY AND NEURODEGENERATIVE DISORDERS”
- Elvira del Pozo, Fundación para la investigación del Hospital Clínico de la Comunidad Valencia, INCLIVA (Spain) ” INCLIVA Biomedical Research Institute”
- Fernando Torres Andón, INIBIC/CHUAC (Spain) ”Macrophage reprogramming for cancer treatment”
- Frank Bosmans, VUB – Vrije Universiteit Brussel (Belgium) ” Targeting Ion Channelopathies in Autonomic and Sensory Disorders: From Genetics to Peptide-Based Therapeutics”
- George Suciu, BEIA (Romania) “HEALTH TELEMETRY”
- Georgina Kyriakoudes, Dcentric Health Ltd (Aria Health) (Cyprus) “Accelerating Patient Engagement and Data Capture for Horizon Health Projects”
- Gianpaolo Ruocco, Initiatives for Bio-Materials Behavior Srls (Italy) “Translational Breast Cancer Research through Digital Twins”
- Gil Katz, IMBM - Institute for Medical BioMathematics (Israel) “Main interest: Predicting Disease Progression and Response to Treatments”
- Giovanni Dattino, DS Medica Milan (Italy) “A new Software for Ocular Eye Surface pathologies”
- Işık Özge Yumurtacı Hüseyinoğlu, Izmir University of Economics (Turkey) “Communicating Care for Well-Being and Social Inclusion (Improving communication with Cancer Patients and Patient Companions in Healthcare)”
- Ivana Stojanović, Institute for Biological Research “Siniša Stanković” (Serbia) “Expertise in the animal autoimmunity models and multicolor flow cytometry”
- Jan Dominik Kampmann, Universityhospital of Southern Denmark (Denmark) “OPtimising Troponin Interpretation and Use AMong Individuals with Reduced Kidney Function – OPTIMIR”
- Jan Korabecny, Biomedical Research Center, University Hospital Hradec Kralove – UHHK (Czech Republic) ”Tuberculosis (TB) Drug Discovery”
- Javier Moreno, TRC INFORMÁTICA S.L (Spain) “Join Forces with TRC: Driving Innovation in European Healthcare”
- Jessica Sutherland, University of Warwick (UK) “IERG, University of Warwick”
- Jingjing Lin, Lazzaro Spallanzani National Institute for Infectious Diseases – INMI (Italy) “Strengthening Research Readiness for Pandemics: INMI Spallanzani Ready to Collaborate”
- Judith Guasch, SpanishNationalResearchCouncil –Institute of Materials Science of Barcelona (Spain) “ Artificial extracellular matrices for oncological applications”
- Koen Maertens, OSCARE (Belgium) “Oscare: Excellence in Burn and Scar Management”
- Kostiantyn Kuts, State Institution "National Research Center for Radiation Medicine, Hematology and Oncology of National Academy of Medical Sciences of Ukraine" (Ukraine) “Investigation of the effects of device-assisted neurorehabilitation in Ukrainian servicemen with PTSD in various psychotraumatic conditions”
- Kyoko Jansson, NouiLife (Sweden) “IMPACT-CARE”
- Lara Gervaise, Virtuosis Ai (Switzerland) “Voice biomarker AI technology”
- Laura Poza Viejo, School of Medicine, UAM (Spain) ”Integrated Platform for the Discovery and Preclinical Validation of Multitarget Neuroprotective Drugs”
- Laurène Mathey, European Health Management Association – EHMA (Belgium) “EHMA- Your partner for improving the sustainability and effectiveness of European health systems”
- Luanna Eroles, Happy Kids Academy (Luxembourg) “The Book of Life – Preventive Mental Health Care powered by AI”
- Luca Giulio Brayda, Nextage srl (Italy) “AI-powered platforms for Health”
- Luciana Mandrioli, University of Bologna (Italy) “In vitro brain aquatic models for studying effects of emerging pollutants”
- Magdalena Kogut, Timelex BV (Belgium) “MATCHING LAW & INNOVATION”
- Marco Mannisi, MEDERE (Italy) “Orthofactory3D – A digital platform for custom orthopedic devices”
- Maria Angeles Juanes, CIPF (Spain) “Molecular mechanisms controlling cancer invasion and metabolism”
- Maria Kitsara, Bioemtech (Greece) “Preclinical imaging modalities combining in vivo studies in small animals and AI/ML”
- Maria Rujano, ECRIN (France) “ECRIN, infrastructure for multinational clinical studies in Europe”
- Mark Gontsarik, CESPE - Centre of Excellence in Sustainable Pharmaceutical Engineering & Manufacturing (Belgium) “Personalised Dosage Forms for Mental, Behavioural, and Neurodevelopmental Disorders”
- Meir Azulay, BioXl (Israel) “CancerPredict - Rapid and reliable test, for improved breast cancer prediction”
- Meir Azulay, BioXl (Israel) “CeaseCancer - Pancreatic cancer drug treatment, combined with chemotherapy”
- Meir Azulay, BioXl (Israel) “NES-Pharma - Combined treatment to prevent cognitive decline from MCI to Dementia in Neurodegenerative diseases”
- Michelle Keller, Pure-DEL (Switzerland) ” Drug Discovery for the Challenging & ‘Undruggable’ - High-quality Data for ML”
- Mick Finlay & Lewis Goodings, Anglia Ruskin University, Cambridge (UK) “Evaluating technological solutions for improving quality of life for people with severe and profound intellectual disabilities”
- Minos Matsoukas, Cloudpharm (Greece) “Computer aided R&D to revolutionize pharmaceutical products and applications”
- Molly Eleanor, School of Medicine, Trinity College Dublin (Ireland) “Better Health Outcomes for the wider Down Syndrome Community”
- Monica Ortenzi, Università Politecnica delle Marche (Italy) “Surgical Assessment Framework Enhanced by AI (SAFE-AI)”
- Nerijus Bernotas, Wellgem Biopharma (Lithuania) ”Offering services to various consortiums for biologics development / testing & manufacturing”
- Neta Harel, NetaInnovation - consultancy & grant writing (Israel) “Transforming Healthcare & Welfare Through Innovation”
- Nicola Kielland, IDIAP Jordi Gol - CATALAN INSTITUTE OF HEALTH (Spain) “Primary Care, a Real-World Environment”
- Nicolas Degauque & Sophie Brouard, INSERM (France) “Decoding B and CD8⁺ T Cell Regulation in Kidney Transplantation”
- Onur Ezgi Gezen, Abdi İbrahim Pharmaceuticals (Turkey) “Abdi İbrahim Pharmaceuticals”
- Paloma Diaz-Gutierrez, Vrije Universiteit Brussel (Belgium) “Targeted Neuromodulation for Depression in Alzheimer’s disease (AD)”
- Patrick Duflot, Liège University Hospital (Belgium) “CHU Liège Digital Health innovation unit”
- Petr Vodicka, Institute of Animal Physiology and Genetics, CAS (Czech Republic) “PIGMOD Centrepartner for biomedical research”
- Regina Oladokun, University Hospital (Nigeria) ”Infectious diseases”
- Sengeziwe Sibeko, Human Sciences Research Council (South Africa) "Chroniccare management modelsat the primaryhealthcarelevelin South Africaand Eswatini: Integrated ChronicDiseasesManagement (ICDM) and the Integrated ClinicalServices Management (ICSM)"
- Sian Taylor-Phillips & Anna Mae Scott, The University of Warwick (UK) “International Evidence Synthesis for Health Screening”
- Srđan Kožetinac, Cluster of medical and health tourism (Serbia) “Cluster of medical and HT”
- Stefan Vermeulen, HOGENT university (Belgium) ” An integrated solution for accurate automated phage quantification and potency testing”
- Stefano Sani, Accademia Nazionale di Medicina (Italy) “Impactful Dissemination and Communication through Experience and Innovation”
- Stéphane Hocquet, Centre de Recherche de l’Industrie Belge de la Céramique (Belgium) “BIO-PACT : Bioreactor platforms for advanced cell therapies”
- Tero Koivisto, University of Turku (Finland) “PAH – Pulmonary Artery Hypertension”
- Thomas Brenner, University of Marburg (Germany) “Impact of environment conditions on health development”
- Tim Robbins, University Hospitals Coventry & Warwickshire NHS Trust (UK) “UHCW NHS Trust: A UK Based “Horizon Experienced” NHS Trust”
- Tony Szturm, University of Manitoba (Canada) “Computer-aided AI-Powered Game-Based Rehabilitation / Telerehabilitation Platform Increase engagement, accessibility and accountability of Rehab for people with Chronic Neurological disorders/Injuries”
- Valentin Popescu, Martel Innovate (Switzerland & the Netherlands) “Martel Innovate, strategic partner in coordination, communication, dissemination, and innovation for health projects”
- Valerio Pini, Mecwins S.A. (Spain) “Reshaping Medical Diagnostics”
- Vana Akraoui, E-Seniors Association (France)
- Vytautas Ostasevicius, University of Technology (Lithuania) “Method and technique for non-invasive blood stimulation’
- William Kavanagh, Abertay University (UK) ”XR for healthcare innovations”
- Zongru Shao, Silicon Austria Labs (Austria) “Enhancing Therapeutic LLM Agents
